Viemed Healthcare price to free cash flow VMD

Market value divided by free cash flow over the last twelve months, since 2020.

Today, Oct 23, 2026: 12.8×
6-year median: 34.0×
Against its 6-year history: 9th; percentile: 0 is its lowest day, 100 its highest
6-year range: 9.1× to 279×
Peer median: 12.5×

Viemed Healthcare's price to free cash flow is 12.8× as of Oct 23, 2026.

That is below its 6-year median of 34.0×, lower than on 91% of days in the last 6 years.

Over that time it ranged from 9.1× in Jul 2021 to 279× in Jun 2020.

The median for 10 hospital and care facility stocks of a similar size is 12.5×.

Price to free cash flow over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	12.8×	11.5×	61.4×
2025	51.5×	45.0×	227×
2024	90.5×	16.0×	101×
2023	19.0×	17.3×	92.6×
2022	60.8×	54.9×	127×
2021	121×	9.1×	141×
2020	11.8×	11.8×	279×

Against its peers

Companies in Medical - Care Facilities nearest Viemed Healthcare's size, closest first, today.

Company	Price to free cash flow
VMDViemed Healthcare	12.8×
SBCSBC Medical	8.8×
OMDAOmada Health	51.0×
USPHU S Physical Therapy	20.6×
PNTGPennant	42.2×
ARDTArdent Health	5.7×
HCSGHealthcare Services	11.7×
PGNYProgyny	12.5×
ADUSAddus HomeCare	14.7×
MDPediatrix Medical	10.4×
PRVAPrivia Health	n/m
Peer median	12.5×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Viemed Healthcare

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.